ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 137 filers reported holding ITEOS THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 6.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $149,395 | +11.0% | 10,067 | +2.0% | 0.00% | 0.0% |
| Q1 2024 | $134,626 | -26.1% | 9,870 | -40.7% | 0.00% | +50.0% |
| Q4 2023 | $182,175 | +528.3% | 16,637 | +528.3% | 0.00% | +100.0% |
| Q3 2023 | $28,996 | +121.9% | 2,648 | +168.3% | 0.00% | – |
| Q2 2023 | $13,068 | +108800.0% | 987 | +9.9% | 0.00% | – |
| Q1 2023 | $12 | +71.4% | 898 | +133.2% | 0.00% | – |
| Q4 2022 | $7 | -100.0% | 385 | -96.3% | 0.00% | -100.0% |
| Q3 2022 | $199,000 | +74.6% | 10,446 | +89.0% | 0.00% | 0.0% |
| Q2 2022 | $114,000 | -39.7% | 5,527 | -5.6% | 0.00% | +50.0% |
| Q1 2022 | $189,000 | +87.1% | 5,855 | +169.7% | 0.00% | 0.0% |
| Q4 2021 | $101,000 | +573.3% | 2,171 | +285.6% | 0.00% | – |
| Q3 2021 | $15,000 | -51.6% | 563 | -54.0% | 0.00% | -100.0% |
| Q2 2021 | $31,000 | -24.4% | 1,224 | +1.7% | 0.00% | 0.0% |
| Q1 2021 | $41,000 | +64.0% | 1,203 | +61.5% | 0.00% | 0.0% |
| Q4 2020 | $25,000 | -49.0% | 745 | -62.4% | 0.00% | 0.0% |
| Q3 2020 | $49,000 | – | 1,979 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $36,261,513 | 17.78% |
| Saturn V Capital Management LP | 636,158 | $8,422,732 | 4.67% |
| MPM BioImpact LLC | 1,745,943 | $23,116,285 | 4.66% |
| Boxer Capital, LLC | 2,154,058 | $28,520 | 1.32% |
| RA Capital Management | 4,417,259 | $58,484,509 | 1.10% |
| Octagon Capital Advisors LP | 596,000 | $7,891,040 | 1.10% |
| BVF INC/IL | 1,810,835 | $23,975,455 | 0.67% |
| 683 Capital Management, LLC | 585,000 | $7,745,400 | 0.56% |
| AlphaCentric Advisors LLC | 63,000 | $834,120 | 0.46% |
| DAFNA Capital Management LLC | 98,560 | $1,304,934 | 0.36% |